13All viruses require strategies to inhibit or evade the immunity pathways of cells they 14 infect. The viruses that infect bacteria, bacteriophages (phages), must avoid nucleic-acid 15 targeting immune pathways such as CRISPR-Cas and restriction endonucleases to 16 replicate efficiently 1 . Here, we show that a jumbo phage infecting Pseudomonas 17 aeruginosa, phage ΦKZ, is resistant to many immune systems in vivo, including CRISPR-18 Cas3 (Type I-C), Cas9 (Type II-A), Cas12 (Cpf1, Type V-A), and Type I restriction-19 modification (R-M) systems. We propose that ΦKZ utilizes a nucleus-like shell to protect 20 its DNA from attack. Supporting this, we demonstrate that Cas9 is able to cleave ΦKZ 21 DNA in vitro, but not in vivo and that Cas9 is physically occluded from the shell 22 assembled by the phage during infection. Moreover, we demonstrate that the Achilles 23 heel for this phage is the mRNA, as translation occurs outside of the shell, rendering the 24 phage sensitive to the RNA targeting CRISPR-Cas enzyme, Cas13a (C2c2, Type VI-A).
25Collectively, we propose that the nucleus-like shell assembled by jumbo phages enables 26 potent, broad spectrum evasion of DNA-targeting nucleases.
28Phage infection and replication can cause bacterial death via cell lysis, necessitating protective 29 immune systems to negate this great threat to bacterial viability 2,3 . Restriction-modification (R-30 M) and adaptive CRISPR-Cas (clustered regularly interspaced short palindromic repeats and 31 CRISPR-associated genes) immunity detect and degrade phage nucleic acids to protect the 32 host 1 . Recent CRISPR-Cas discovery efforts have led to the characterization of six distinct 33 CRISPR-Cas types (I-VI) with independent mechanisms for CRISPR RNA (crRNA) biogenesis, 34 surveillance complex assembly, substrate selection, and target degradation 4 . Type III and VI
35CRISPR-Cas systems target RNA 5,6 , while Types I, II, and V predominantly target DNA 7-9 .
36Despite these differences, all characterized CRISPR-Cas systems function via crRNA-guides 37 derived from the DNA-based CRISPR array, which stores the memory of past infections 10,11 .
39Phages that infect Pseudomonas aeruginosa avoid CRISPR-mediated destruction by encoding 40 "anti-CRISPR" (Acr) proteins that inhibit the Type I-E and I-F CRISPR-Cas systems [12][13][14] . We 41 sought to determine whether any P. aeruginosa phages are also resistant to the Type I-C 42 CRISPR-Cas subtype, also present in P. aeruginosa 15 . This subtype is notable as it is the most 43 minimal Type I system identified to date, is highly abundant in bacterial genomes 16 , and is 44 understudied relative to other subtypes. We identified an isolate in our lab encoding a Type I-C 45 system, and designed and expressed a crRNA targeting related phages JBD30 and DMS3m, 48 phages did not possess functional Type I-C Acr proteins ( Fig. 1a). To test the sensitivity of other 49 phage families against the Type I-C system, we transferred the necessary cas genes (cas3, 50 cas5, cas8, cas7) into the chromosome of a...